Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. META
2. PEP
3. USO
4. SPY
5. WRAP
6. KBH
7. IONS
8. DAL
9. NVDA
10. CRCL

Go back to Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
(NASDAQ: RVMD) Delayed: 191.13 --0 (-0%)
Previous Close $191.13    52 Week High $ 
Open $191.13    52 Week Low $ 
Day High $191.13    P/E N/A 
Day Low $191.13    EPS $ 
Volume 1,370